SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-002257
Filing Date
2023-01-24
Accepted
2023-01-24 06:05:09
Documents
1
Period of Report
2023-01-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3084
  Complete submission text file 0001493152-23-002257.txt   4385
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Issuer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2311 SPARTAN TRAIL SUGAR LAND TX 77479
Business Address
Patel Snehal (Reporting) CIK: 0001806920 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39555 | Film No.: 23545800